• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Axial spondyloarthritis and psoriatic arthritis : Current results and assessments].

作者信息

Braun J

机构信息

Rheumazentrum Ruhrgebiet, Marienhospital Herne, Ruhr Universität Bochum, Claudiusstr. 45, 44649, Herne, Deutschland.

出版信息

Z Rheumatol. 2020 Feb;79(1):1-4. doi: 10.1007/s00393-020-00753-y.

DOI:10.1007/s00393-020-00753-y
PMID:32040748
Abstract
摘要

相似文献

1
[Axial spondyloarthritis and psoriatic arthritis : Current results and assessments].[轴性脊柱关节炎和银屑病关节炎：当前结果与评估]
Z Rheumatol. 2020 Feb;79(1):1-4. doi: 10.1007/s00393-020-00753-y.
2
Suspecting and Diagnosing the Patient with Spondyloarthritis and What to Expect from Therapy.怀疑和诊断患有脊椎关节炎的患者以及对治疗的预期。
Rheum Dis Clin North Am. 2022 May;48(2):507-521. doi: 10.1016/j.rdc.2022.02.008.
3
Disease activity measurements and monitoring in psoriatic arthritis and axial spondyloarthritis.银屑病关节炎和中轴型脊柱关节炎的疾病活动度测量和监测。
Best Pract Res Clin Rheumatol. 2014 Oct;28(5):711-28. doi: 10.1016/j.berh.2014.10.004. Epub 2014 Nov 7.
4
Clearing the fog: A closer look at the differences between axial psoriatic arthritis and axial spondyloarthritis.拨开迷雾：深入探究轴性银屑病关节炎与轴性脊柱关节炎之间的差异
ARP Rheumatol. 2023 Jan-Mar;2(1):3-6.
5
Axial spondyloarthritis and psoriatic arthritis: mostly overlapping or substantially different diseases?轴性脊柱关节炎和银屑病关节炎：主要是重叠性疾病还是截然不同的疾病？
RMD Open. 2023 May;9(2). doi: 10.1136/rmdopen-2023-003063.
6
Same, same or different? Commonalities and differences between spondyloarthritis and its subsets of axial and peripheral spondyloarthritis with psoriatic arthritis and its diverse phenotypes.相同还是不同？脊柱关节炎及其轴向和外周型脊柱关节炎亚组与银屑病关节炎及其多种表型之间的共性与差异。
RMD Open. 2023 Apr;9(2). doi: 10.1136/rmdopen-2022-002872.
7
Spondyloarthritides.脊柱关节炎。
Immunol Allergy Clin North Am. 2023 Aug;43(3):593-612. doi: 10.1016/j.iac.2022.10.001.
8
Axial Psoriatic Arthritis: A Distinct Clinical Entity in Search of a Definition.轴性银屑病关节炎：一种寻求定义的独特临床实体。
Rheum Dis Clin North Am. 2020 May;46(2):327-341. doi: 10.1016/j.rdc.2020.01.009.
9
Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study.强直性脊柱炎、银屑病关节炎和未分化脊柱关节炎是否与心血管事件风险增加相关？一项基于全国人群的前瞻性队列研究。
Arthritis Res Ther. 2017 May 18;19(1):102. doi: 10.1186/s13075-017-1315-z.
10
[Spondyloarthritis: new names for old acquaintances].[脊柱关节炎：旧相识的新名称]
Ned Tijdschr Geneeskd. 2014;158:A7820.

本文引用的文献

1
Development of ASAS quality standards to improve the quality of health and care services for patients with axial spondyloarthritis.制定 ASAS 质量标准，以提高患有中轴型脊柱关节炎患者的健康和医疗服务质量。
Ann Rheum Dis. 2020 Feb;79(2):193-201. doi: 10.1136/annrheumdis-2019-216034. Epub 2019 Oct 11.
2
A Fifty-Two-Week, Randomized, Placebo-Controlled Trial of Certolizumab Pegol in Nonradiographic Axial Spondyloarthritis.培塞丽珠单抗治疗非放射性中轴型脊柱关节炎的 52 周、随机、安慰剂对照试验。
Arthritis Rheumatol. 2019 Jul;71(7):1101-1111. doi: 10.1002/art.40866. Epub 2019 May 28.
3
Secukinumab shows sustained efficacy and low structural progression in ankylosing spondylitis: 4-year results from the MEASURE 1 study.
司库奇尤单抗治疗强直性脊柱炎的疗效持久且结构进展低：MEASURE 1 研究的 4 年结果。
Rheumatology (Oxford). 2019 May 1;58(5):859-868. doi: 10.1093/rheumatology/key375.
4
Impact of baseline C-reactive protein levels on the response to secukinumab in ankylosing spondylitis: 3-year pooled data from two phase III studies.基线C反应蛋白水平对强直性脊柱炎患者司库奇尤单抗治疗反应的影响：两项III期研究的3年汇总数据
RMD Open. 2018 Nov 21;4(2):e000749. doi: 10.1136/rmdopen-2018-000749. eCollection 2018.
5
Active and chronic sacroiliitis, spondylitis and enthesitis, How specific are imaging findings for axial spondyloarthritis?活动性和慢性骶髂关节炎、脊柱炎和附着点炎，轴向型脊柱关节炎的影像学表现有多特异？
Rheumatology (Oxford). 2019 Aug 1;58(8):1321-1324. doi: 10.1093/rheumatology/key372.
6
Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trial.选择性 Janus 激酶 1 抑制剂 filgotinib 治疗活动性强直性脊柱炎患者的疗效和安全性（TORTUGA）：一项随机、安慰剂对照、2 期临床试验的结果。
Lancet. 2018 Dec 1;392(10162):2378-2387. doi: 10.1016/S0140-6736(18)32463-2. Epub 2018 Oct 22.
7
Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial.依奇珠单抗，一种白细胞介素-17A 拮抗剂，用于治疗先前未接受生物疾病修饰抗风湿药物（COAST-V）治疗的强直性脊柱炎或放射学中轴型脊柱关节炎患者：一项 3 期随机、双盲、活性对照和安慰剂对照试验的 16 周结果。
Lancet. 2018 Dec 8;392(10163):2441-2451. doi: 10.1016/S0140-6736(18)31946-9. Epub 2018 Oct 22.
8
Efficacy and Safety of Ixekizumab in the Treatment of Radiographic Axial Spondyloarthritis: Sixteen-Week Results From a Phase III Randomized, Double-Blind, Placebo-Controlled Trial in Patients With Prior Inadequate Response to or Intolerance of Tumor Necrosis Factor Inhibitors.依奇珠单抗治疗影像学轴向型脊柱关节炎的疗效和安全性：在先前对肿瘤坏死因子抑制剂反应不足或不耐受的患者中进行的一项为期 16 周的 III 期随机、双盲、安慰剂对照试验的结果。
Arthritis Rheumatol. 2019 Apr;71(4):599-611. doi: 10.1002/art.40753. Epub 2019 Mar 8.
9
Imaging of axial spondyloarthritis. New aspects and differential diagnoses.轴向型脊柱关节炎的影像学。新的方面和鉴别诊断。
Clin Exp Rheumatol. 2018 Sep-Oct;36 Suppl 114(5):35-42. Epub 2018 Oct 1.
10
Three Multicenter, Randomized, Double-Blind, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Ustekinumab in Axial Spondyloarthritis.三项多中心、随机、双盲、安慰剂对照研究评估乌司奴单抗在中轴型脊柱关节炎中的疗效和安全性。
Arthritis Rheumatol. 2019 Feb;71(2):258-270. doi: 10.1002/art.40728. Epub 2018 Dec 29.